52 related articles for article (PubMed ID: 33599311)
1. Development of a simultaneous analytical method for clozapine and its metabolites in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry with linear range adjusted by in-source collision-induced dissociation.
Sato T; Suzuka M; Sato Y; Iwabuchi R; Kobayashi D; Ogura J; Takasaki S; Yokota M; Tsukamoto T; Hayakawa Y; Kikuchi M; Maekawa M; Mano N
Biomed Chromatogr; 2021 Jul; 35(7):e5094. PubMed ID: 33599311
[TBL] [Abstract][Full Text] [Related]
2. Novel Identification of Cysteinyl Derivatives of Toxic Clozapine Nitrenium Ions and the Effect of Valproic Acid on Metabolite Formation: A Study Using Reprocessed High-Resolution Mass Spectra of Analyzed Therapeutic Drug Monitoring Samples.
Wollmann BM; Haugen AG; Smith RL; Molden E
Ther Drug Monit; 2024 Apr; 46(2):265-269. PubMed ID: 38287885
[TBL] [Abstract][Full Text] [Related]
3. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
Smith RL; O'Connell K; Athanasiu L; Djurovic S; Kringen MK; Andreassen OA; Molden E
Transl Psychiatry; 2020 Jun; 10(1):198. PubMed ID: 32555152
[TBL] [Abstract][Full Text] [Related]
5. Effect of lemborexant on pharmacokinetics of clozapine: A potential drug-drug interaction mediated by time-dependent inhibition of CYP3A4.
Watanabe K; Misaka S; Kanno-Nozaki K; Chiyoda T; Suzuki Y; Sato A; Suto T; Kuroda J; Shimomura K; Miura I; Yabe H
Br J Clin Pharmacol; 2024 Jan; 90(1):354-359. PubMed ID: 37596710
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of clozapine in human serum by high-throughput paper spray mass spectrometry.
Saatchi A; Zarkovic TM; Borden SA; Palaty J; Gill CG
J Mass Spectrom Adv Clin Lab; 2024 Apr; 32():41-46. PubMed ID: 38419980
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.
Schaber G; Stevens I; Gaertner HJ; Dietz K; Breyer-Pfaff U
Br J Clin Pharmacol; 1998 Nov; 46(5):453-9. PubMed ID: 9833598
[TBL] [Abstract][Full Text] [Related]
8. A retrospective study of clozapine and norclozapine concentration in patients with schizophrenia: Data from the Therapeutic Drug Monitoring Service, 2019-2022.
Ding J; Liu J; Zhang Y; Xing H; Zhang Y; Li L; Zhang S; Wang H; Yang L; Cui X
Asian J Psychiatr; 2024 Jan; 91():103865. PubMed ID: 38113699
[TBL] [Abstract][Full Text] [Related]
9. Domain-Limited Sub-Nanometer Co Nanoclusters in Defective Nitrogen Doped Carbon Structures for Non-Invasive Drug Monitoring.
Yu Z; Tang J; Gao Y; Wu D; Chen S; Zeng Y; Tang D; Liu X
Small; 2024 Apr; 20(16):e2309264. PubMed ID: 38010948
[TBL] [Abstract][Full Text] [Related]
10. Association of clozapine and norclozapine levels with patient and therapy characteristics-focus on interaction with valproic acid.
Panić B; Jovanović M; Lukić V; Vučićević K; Miljković B; Milovanović S
Eur J Clin Pharmacol; 2023 Nov; 79(11):1557-1564. PubMed ID: 37733278
[TBL] [Abstract][Full Text] [Related]
11. Assessing Adherence to Clozapine: Practical Considerations.
Flanagan RJ; Hunter S; Obee SJ
J Clin Psychopharmacol; 2023 Sep-Oct 01; 43(5):417-421. PubMed ID: 37683230
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality.
Manca A; Mula J; Palermiti A; Vischia F; Cori D; Venturello S; Emanuelli G; Maiese D; Antonucci M; Nicolò A; Vivo ED; Cusato J; D'Avolio A
Biomed Pharmacother; 2023 Sep; 165():115103. PubMed ID: 37413901
[TBL] [Abstract][Full Text] [Related]
13. CYP-catalysed cycling of clozapine and clozapine-
Kingston E; Tingle M; Bellissima BL; Helsby N; Burns K
Xenobiotica; 2024 Jan; 54(1):26-37. PubMed ID: 38108307
[TBL] [Abstract][Full Text] [Related]
14. Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience.
Breken BD; Grootens KP; Vermeulen Windsant-van den Tweel AM; Hermens WA; Derijks HJ
Int Clin Psychopharmacol; 2024 Jan; 39(1):23-28. PubMed ID: 37551596
[TBL] [Abstract][Full Text] [Related]
15. Chromatographic Methods for the Analysis of the Antipsychotic Drug Clozapine and Its Major Metabolites: A Review.
Hrichi H; Kouki N; Elkanzi NAA
J Chromatogr Sci; 2024 Apr; ():. PubMed ID: 38576210
[TBL] [Abstract][Full Text] [Related]
16. The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study.
Banis GE; Winkler T; Barton P; Chocron SE; Kim E; Kelly DL; Payne GF; Ben-Yoav H; Ghodssi R
Pharmaceuticals (Basel); 2017 Aug; 10(3):. PubMed ID: 28763030
[TBL] [Abstract][Full Text] [Related]
17. Effects of smoking cessation on plasma clozapine concentrations in male patients with schizophrenia during the COVID-19 pandemic.
Ma B; Fan H; Qi S; Yang F; An H
Front Psychiatry; 2023; 14():1256264. PubMed ID: 37779619
[TBL] [Abstract][Full Text] [Related]
18. Abnormal blood concentration changes in a 71-year-old female who survived a 10,000mg overdose of clozapine: a case report.
Wu Y; Zhou Z; Ai Z; Wang T; Cui L
BMC Psychiatry; 2024 Feb; 24(1):123. PubMed ID: 38355481
[TBL] [Abstract][Full Text] [Related]
19. Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction.
Wiss FM; Allemann SS; Meyer Zu Schwabedissen HE; Stäuble CK; Mikoteit T; Lampert ML
Front Psychiatry; 2024; 15():1397876. PubMed ID: 38742124
[TBL] [Abstract][Full Text] [Related]
20. Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients.
Lozano R; Bona C
J Res Pharm Pract; 2023; 12(1):29-31. PubMed ID: 38213602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
